Fundz

ATRO Medical secures €3 million in funding to advance its artificial meniscus towards pivotal studies, led by investors from the Netherlands, Switzerland, and UAE.

PRIVATEFeb 25, 2026

Amount Raised

€3 Million

Round Type

Seed

NetherlandsBiotechnologyHealth CareMedicalMedical Device

Investors

SamaplastDsm Firmenich VenturesBolwork International InvestmentThuja Capital819 Capital

Description

ATRO Medical has successfully closed a €3 million financing round to advance its clinical studies on the artificial meniscus implant. MedTech investors from across Europe and the UAE participated in this round. The funds will be utilized for clinical evidence generation and preparing for pivotal trials. ATRO Medical's advancements reflect growing international confidence in its technology and strategy.

Quick answer

ATRO Medical raised €3 Million in a Seed round, dated February 25, 2026. Investors: Samaplast, Dsm Firmenich Ventures, Bolwork International Investment, Thuja Capital and 819 Capital. ATRO Medical is based in Netherlands.

How much did ATRO Medical raise?
ATRO Medical raised €3 Million in a Seed round on February 25, 2026.
Who invested in ATRO Medical?
Samaplast, Dsm Firmenich Ventures, Bolwork International Investment, Thuja Capital and 819 Capital are named as investors in this round.
What does ATRO Medical do?
ATRO Medical is a Dutch clinical-stage orthopedic company focused on developing a novel artificial meniscus implant for patients suffering from post-meniscectomy pain.
Where is ATRO Medical based and how big is it?
ATRO Medical is based in Netherlands.
Who are the decision-makers at ATRO Medical?
Fundz holds 1 contact at ATRO Medical, including the Project Manager. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as ATRO Medical that raised within 45 days of this round, from Fundz verified event records.

  • PanTera raised $4M on March 31, 2026.
  • Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
  • Sub-Q Bionics raised $1.5M (Pre-Seed) on March 31, 2026.
  • IceCure Medical raised $4M on March 26, 2026.
  • Combat Medical raised $3.5M (Series A) on March 12, 2026.
  • Monteris Medical raised $28M (Series E) on March 12, 2026.

Who to call at ATRO Medical, and when

A new round usually means ATRO Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ATRO Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ATRO Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ATRO Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ATRO Medical

Location

Netherlands

About

ATRO Medical is a Dutch clinical-stage orthopedic company focused on developing a novel artificial meniscus implant for patients suffering from post-meniscectomy pain. The company is advancing its latest Artimis® Meniscus Prosthesis design through clinical evaluations and aims to expand evidence generation for pivotal clinical trials in the US and Europe. With a strong leadership team and recent successes, ATRO Medical is positioned for growth in the medical device sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ATRO Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRick V., Project Manager hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ATRO Medical's next move

See what Strategic adds

ATRO Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.